Laboratory Analysis Indicates GlaxoSmithKline’s COVID-19 Therapy Effective Against Omicron Variant, Company Says
December 03, 2021
Reuters (12/2, Burger) reports, “Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (GSK) is developing with U.S. partner Vir has indicated the drug is effective against the new Omicron variant, the British drugmaker said on Thursd...